Kratom Use Is Underestimated, but Prevalence Still Appears to Be Low
- PMID: 34922652
- PMCID: PMC8697708
- DOI: 10.1016/j.amepre.2021.07.021
Kratom Use Is Underestimated, but Prevalence Still Appears to Be Low
Comment on
-
Past-Year Kratom Use in the U.S.: Estimates From a Nationally Representative Sample.Am J Prev Med. 2021 Aug;61(2):240-245. doi: 10.1016/j.amepre.2021.02.004. Epub 2021 Apr 29. Am J Prev Med. 2021. PMID: 34027890 Free PMC article.
-
We Need Better Estimates of Kratom Use Prevalence.Am J Prev Med. 2022 Jan;62(1):132-133. doi: 10.1016/j.amepre.2021.07.022. Am J Prev Med. 2022. PMID: 34922651 No abstract available.
References
-
- Henningfield JE, Grundmann O, Garcia-Romeu A, Swogger MT. We need better estimates of kratom use prevalence. Am J Prev Med. In press. - PubMed
-
- Palamar JJ, Martins SS, Su MK, Ompad DC. Self-reported use of novel psychoactive substances in a U.S. nationally representative survey: prevalence, correlates, and a call for new survey methods to prevent underreporting. Drug Alcohol Depend. 2015;156:112–119. 10.1016/j.drugalcdep.2015.08.028. - DOI - PMC - PubMed
-
- Center for Behavioral Health Statistics and Quality, 2018 National Survey on Drug Use and Health public use file codebook, 2019. Substance Abuse and Mental Health Services Administration; Rockville, MD. https://www.datafiles.samhsa.gov/sites/default/files/fielduploads-protec.... Published October 22, 2019. Accessed October 19, 2021.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
